English
Back
Download
Log in to access Online Inquiry
Back to the Top

News

$Revance Therapeutics (RVNC.US)$ Press Release: Teoxane SA Announces Superior Proposal to Acquire Revance Therapeutics for $3.60 per Share in Cash
Dow Jones· 1 min ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
1886 Views
Comment
Sign in to post a comment
    4509
    Followers
    25
    Following
    64K
    Visitors
    Follow
    Discussing
    Trump 2.0 Era: What's the next opportunity in the markets?
    ▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks Show More